These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33691016)

  • 1. Drug Response Pharmacogenetics for 200,000 UK Biobank Participants.
    McInnes G; Altman RB
    Pac Symp Biocomput; 2021; 26():184-195. PubMed ID: 33691016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
    Solhaug V; Molden E
    Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics at Scale: An Analysis of the UK Biobank.
    McInnes G; Lavertu A; Sangkuhl K; Klein TE; Whirl-Carrillo M; Altman RB
    Clin Pharmacol Ther; 2021 Jun; 109(6):1528-1537. PubMed ID: 33237584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport].
    Allorge D; Loriot MA
    Ann Biol Clin (Paris); 2004; 62(5):499-511. PubMed ID: 15355800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of a placebo/nocebo effect in pharmacogenetics.
    Haga SB; Warner LR; O'Daniel J
    Public Health Genomics; 2009; 12(3):158-62. PubMed ID: 19204418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of drug transporters in the enterohepatic circulation.
    Stieger B; Meier PJ
    Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy and pharmacogenomics--hopes and facts].
    Müller-Zellenberg U; Müller M
    Wien Med Wochenschr; 2005 Feb; 155(3-4):45-9. PubMed ID: 15791775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of pharmacogenetics for individualizing drug treatment and for study design.
    Meisel C; Gerloff T; Kirchheiner J; Mrozikiewicz PM; Niewinski P; Brockmöller J; Roots I
    J Mol Med (Berl); 2003 Mar; 81(3):154-67. PubMed ID: 12682724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consent in psychiatric biobanks for pharmacogenetic research.
    van der Baan FH; Bernabe RD; Bredenoord AL; Gregoor JG; Meynen G; Knol MJ; van Thiel GJ
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):677-82. PubMed ID: 22607776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing recommendations for pharmacogenetic interactions related to drug metabolism.
    Filipski KK; Pacanowski MA; Ramamoorthy A; Feero WG; Freedman AN
    Pharmacogenet Genomics; 2016 Jul; 26(7):334-9. PubMed ID: 27058883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
    Shah RR
    Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing relevance of pharmacogenetics of drug metabolism in clinical practice.
    Pillans PI
    Intern Med J; 2001 Nov; 31(8):476-8. PubMed ID: 11720061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The missing linkage: what pharmacogenetic associations are left to find in CYP3A?
    Perera MA
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):17-28. PubMed ID: 19968573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics/genomics and drug effects.
    Heller F
    Acta Clin Belg; 2013; 68(2):77-80. PubMed ID: 23967712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.